Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro

• Sandra Sernbo,

  Affiliation Department of Immunotechnology, CREATE Health, Lund University, Lund, Sweden

  ⨯
• Carl A. K. Borrebaeck,

  Affiliation Department of Immunotechnology, CREATE Health, Lund University, Lund, Sweden

  ⨯
• Mathias Uhlén,

  Affiliation Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm, Sweden

  ⨯
• Karin Jirström,

  Affiliation Department of Clinical Sciences, Division of Pathology, Lund University, Skåne University Hospital, Lund, Sweden

  ⨯
• Sara Ek

  * E-mail: sara.ek@immun.lth.se

  Affiliation Department of Immunotechnology, CREATE Health, Lund University, Lund, Sweden

  ⨯